Overall Status

Recruiting (11)

Completed (6)

Not yet recruiting (5)

Enrolling by invitation (3)

Unknown status (3)

Terminated (1)

Phase

n/a (9)

phase 2 (7)

early phase 1 (5)

phase 1 (4)

phase 4 (2)

phase 1/phase 2 (1)

Collaborator

National Cancer Institute (NCI) (2)

National Center for Complementary and Integrative Health (NCCIH) (1)

National Heart, Lung, and Blood Institute (NHLBI) (1)

National Institute for Biomedical Imaging and Bioengineering (NIBIB) (1)

National Institutes of Health (NIH) (1)

National Science Council, Taiwan (1)

Ontario Institute for Cancer Research (1)

Study Documents

Intervention Type

drug (29)

device (3)

procedure (2)

other (1)

radiation (1)

Funder Type

Other (27)

Industry (1)

NIH (1)

Study Type

Interventional (28)

Observational (1)

18f-fdg

Showing 26 - 29 of 29

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Pituitary Adenoma Trial in Beijing (18F-FDG)

Unknown status

Pituitary Adenoma

18F-FDG

Beijing, Beijing, China

Peking Union Medical College Hospital

Jan 12, 2018

Autoimmune Disease Trial in Beijing (18F-FDG)

Unknown status

Autoimmune Disease

18F-FDG

Beijing, Beijing, China

Peking Union Medical College Hospital

Apr 5, 2017

Alzheimer's Disease, Frontotemporal Dementia Trial in Manchester (florbetapir 18F, 18F-FDG)

Completed

Has Results

Alzheimer's Disease
Frontotemporal Dementia

florbetapir 18F
18F-FDG

Manchester, United Kingdom

Research Site

Sep 16, 2014

Parkinson's Disease Trial in Taoyuan (18F-FDG)

Completed

Parkinson's Disease

18F-FDG

Taoyuan, Taiwan

Chang Gung Memory Hpspital

Nov 10, 2013